• Your shopping cart is empty!

  • CLSI M33-A

CLSI M33-A

Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE

Clinical and Laboratory Standards Institute, 02/01/2004

Publisher: CLSI

File Format: PDF

$120.00$240.30


Published:01/02/2004

Pages:39

This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.

More CLSI standard pdf

CLSI H18-A3

CLSI H18-A3

Procedures for the Handling and Processing of Blood Specimens; Approved Guideline

$111.00 $223.88

CLSI HS01A2

CLSI HS01A2

A Quality Management System Model for Health Care; Approved Guideline, HS01-A2

$137.00 $274.67

CLSI C45-A

CLSI C45-A

Measurement of Free Thyroid Hormones; Approved Guideline , C45AE

$108.00 $217.61

CLSI GP45-A

CLSI GP45-A

Studies to Evaluate Patient Outcomes; Approved Guideline, GP45AE

$103.00 $206.11